Search for Clinical Trial Results

Sponsored By

Bare Lymphocyte Syndrome - 4 Studies Found

Status Study
Recruiting Study Name: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Condition:
  • SCID
  • Omenn's Syndrome
  • Reticular Dysgenesis
  • Date: 2012-07-25
    Interventions:
    • Drug: Alemtuzumab 0.3 mg 0.3 m
Recruiting Study Name: Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT
Condition:
  • Primary Immunodeficiency Syndromes
  • Congenital Bone Marrow Failure Syndromes
  • Drug: Hydroxyurea Hydroxyurea

Recruiting Study Name: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Condition:
  • SCID
  • Omenn's Syndrome
  • Reticular Dysgenesis
  • Date: 2012-07-25
    Interventions:
    • Drug: Alemtuzumab 0.3 mg 0.3 m
Recruiting Study Name: Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT
Condition:
  • Primary Immunodeficiency Syndromes
  • Congenital Bone Marrow Failure Syndromes
  • Drug: Hydroxyurea Hydroxyurea